These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30088279)

  • 1. Subcutaneous implantable cardioverter defibrillator oversensing and shock delivery due to chest compressions during CPR.
    Berkowitz EJ; Pleimann BE; Rosenfeld LE
    Pacing Clin Electrophysiol; 2018 Dec; 41(12):1687-1690. PubMed ID: 30088279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CPR Induced Inappropriate Shocks from a Subcutaneous Implantable Cardioverter Defibrillator during Out-of-Hospital Cardiac Arrest.
    Cmorej P; Smrzova E; Peran D; Bulikova T
    Prehosp Emerg Care; 2020; 24(1):85-89. PubMed ID: 30905240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator.
    Theuns DAMJ; Brouwer TF; Jones PW; Allavatam V; Donnelley S; Auricchio A; Knops RE; Burke MC
    Heart Rhythm; 2018 Oct; 15(10):1515-1522. PubMed ID: 29758404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management.
    Olde Nordkamp LR; Brouwer TF; Barr C; Theuns DA; Boersma LV; Johansen JB; Neuzil P; Wilde AA; Carter N; Husby M; Lambiase PD; Knops RE
    Int J Cardiol; 2015 Sep; 195():126-33. PubMed ID: 26026928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An "inappropriately appropriate" shock in a subcutaneous implantable cardioverter-defibrillator: The importance of the SMART pass algorithm.
    Rubio Campal JM; Benezet-Mazuecos J; Sánchez-Borque P; Blanco ÁM; Crosa J; Arias MA
    J Electrocardiol; 2018; 51(6):941-944. PubMed ID: 30497752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.
    Basu-Ray I; Liu J; Jia X; Gold M; Ellenbogen K; DiNicolantonio J; Komócsi A; Vorobcsuk A; Kim J; Afshar H; Lam W; Mathuria N; Razavi M; Rasekh A; Saeed M
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1475-1483. PubMed ID: 29759827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous Implantable Cardioverter Defibrillator Lead Repositioning for Preventing Inappropriate Shocks Due to Myopotential Oversensing in a Post-Fulminant Myocarditis Patient.
    Sasaki T; Nakamura K; Naito S
    Int Heart J; 2019 Mar; 60(2):466-469. PubMed ID: 30745542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator.
    Gold MR; Weiss R; Theuns DA; Smith W; Leon A; Knight BP; Carter N; Husby M; Burke MC
    Heart Rhythm; 2014 Aug; 11(8):1352-8. PubMed ID: 24732366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catheter ablation of atrial tachyarrhythmias causing inappropriate implantable cardioverter-defibrillator shocks.
    Miyazaki S; Taniguchi H; Kusa S; Komatsu Y; Ichihara N; Takagi T; Iwasawa J; Kuroi A; Nakamura H; Hachiya H; Hirao K; Iesaka Y
    Europace; 2015 Feb; 17(2):289-94. PubMed ID: 25061229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults.
    Bettin M; Larbig R; Rath B; Fischer A; Frommeyer G; Reinke F; Köbe J; Eckardt L
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1499-1506. PubMed ID: 29759830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of ECG changes on oversensing of subcutaneous implantable cardioverter-defibrillators.
    Hakamata T; Otsuki S; Izumi D; Sakaguchi Y; Suzuki N; Ikami Y; Hasegawa Y; Yagihara N; Iijima K; Chinushi M; Fuse K; Inomata T
    Heart Rhythm; 2022 Oct; 19(10):1704-1711. PubMed ID: 35688344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of bradycardia pacing and detection of ventricular fibrillation due to far-field atrial sensing in a triple chamber implantable cardioverter defibrillator.
    Vollmann D; Lüthje L; Görtler G; Unterberg C
    Pacing Clin Electrophysiol; 2002 Oct; 25(10):1513-6. PubMed ID: 12418750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of inappropriate shocks/T-wave-oversensing in S-ICD®-patients].
    Larbig R; Bettin M; Motloch LJ; Fischer A; Bode N; Frommeyer G; Reinke F; Loeher A; Eckardt L; Köbe J
    Herzschrittmacherther Elektrophysiol; 2018 Mar; 29(1):122-126. PubMed ID: 29435656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An unusual mechanism causing inappropriate implantable cardioverter defibrillator shocks: transient reduction in R-wave amplitude.
    Baranchuk A; Ribas S; Divakaramenon S; Morillo CA
    Europace; 2007 Aug; 9(8):694-6. PubMed ID: 17478463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inappropriate Shock Due to Myopotential Oversensing in a Patient With Subcutaneous Implantable Cardioverter-Defibrillator.
    Alasti M; Machado C; Kotschet E; Alison J
    Heart Lung Circ; 2019 Apr; 28(4):e88-e90. PubMed ID: 30482685
    [No Abstract]   [Full Text] [Related]  

  • 18. The "Pain wave": P‑wave oversensing in subcutaneous ICD.
    Kattih B; Duncker D; König T; Hohmann S; Oswald H; Veltmann C
    Herzschrittmacherther Elektrophysiol; 2016 Jun; 27(2):151-3. PubMed ID: 27084342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.
    Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL
    J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inappropriate shocks due to air entrapment in patients with subcutaneous implantable cardioverter-defibrillator: A meta-summary of case reports.
    Iavarone M; Rago A; Nigro G; Golino P; Russo V
    Pacing Clin Electrophysiol; 2022 Oct; 45(10):1210-1215. PubMed ID: 35983947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.